Varex Imaging Reports Strong Q4 and FY 2025 Results

Varex Imaging Corporation ( (VREX) ) has released its Q4 earnings. Here is a breakdown of the information Varex Imaging Corporation presented to its investors.

Varex Imaging Corporation is a leading innovator in the design and manufacture of X-ray imaging components, serving both medical and industrial sectors with a history of over 70 years in successful innovation. The company, headquartered in Salt Lake City, Utah, employs approximately 2,400 people globally.

In its latest earnings report for the fourth quarter and fiscal year 2025, Varex Imaging Corporation reported strong financial performance, with fourth-quarter revenues reaching $229 million, an 11% increase year-over-year. The fiscal year 2025 revenues totaled $845 million, marking a 4% growth compared to the previous year. The company attributed its growth to robust sales in its Medical and Industrial segments.

Key financial highlights for the fourth quarter included a GAAP gross margin of 34% and a non-GAAP net income of $0.37 per diluted share. The Industrial segment saw a significant 25% increase in sales, driven by the cargo systems business. For the fiscal year, Varex reported a non-GAAP EBITDA growth of 37% to $122 million and a non-GAAP EPS increase of 73% to $0.90.

Despite a GAAP net loss for the fiscal year, Varex made substantial progress in key growth initiatives, such as the development of photon counting technology for CT and the launch of a new radiographic detector from its facility in India. The company also secured over $55 million in orders within its Industrial segment.

Looking ahead, Varex Imaging Corporation anticipates first-quarter fiscal year 2026 revenues between $200 million and $215 million, with non-GAAP net earnings per diluted share expected to range from $0.05 to $0.25. The company remains focused on advancing its growth initiatives and maintaining momentum in its core business segments.